| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Scott Randal W. serves as a Director at BBIO. Across recent SEC filings that breaks down to 1 buy and 17 sells. Those positions are worth an estimated $1.0M at current prices.
Historically, Scott Randal W.'s trades have earned a below-average insider score of 45/100 across 8 rated trades. Over a 12-month horizon, 42.9% of those trades were profitable, with an average 12-month return of -16.9%.
The biggest single holding is BBIO (~$1.0M) as Director. The recent filings there lean toward selling, a net 26,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 10,000 | $67.15 | $671,455.63 | -46.3% | +22.8% | - | |
| Feb 17, 2026 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 10,000 | $75.46 | $754,556.60 | -46.3% | -13.9% | - | |
| Nov 17, 2025 | BBIO Bridgebio Pharma, Inc. | Director | Sale+OE | 10,000 | $66.65 | $666,465.10 | -46.3% | +13.4% | - | |
| Jun 4, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $30.32 | $75,792.52 | -38.5% | +5.9% | +40.1% | |
| Mar 1, 2024 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $34.00 | $85,000.00 | -27.8% | -19.0% | -2.0% | |
| Dec 18, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,000 | $40.00 | $80,000.00 | -18.2% | -27.7% | -27.6% | |
| Dec 1, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $29.40 | $73,500.00 | -18.5% | +10.4% | -12.4% | |
| Sep 5, 2023 | BBIO Bridgebio Pharma, Inc. | Director | Sell | 2,500 | $30.00 | $75,000.00 | -15.6% | +7.8% | +3.5% | |
| Feb 17, 2021 | BBIO Bridgebio Pharma, Inc. | Director | Buy | 16,000 | $62.50 | $1,000,000.00 | +320.0% | -13.9% | -87.1% |